⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for prostatic neoplasm

Every month we try and update this database with for prostatic neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate CancerNCT04484701
Prostatic Neopl...
Prostatic Cance...
68Ga-PSMA-11
19 Years - 99 YearsBritish Columbia Cancer Agency
Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)NCT04332744
Metastatic Pros...
Enzalutamide
Talazoparib
18 Years - MedSIR
Trial of NanoPac Focal Therapy for Prostate CancerNCT04221828
Prostate Cancer
Prostate Adenoc...
Prostate Cancer...
Prostatic Neopl...
Urogenital Neop...
Genital Neoplas...
Localized Cance...
NanoPac (steril...
18 Years - NanOlogy, LLC
Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the ProstateNCT03987737
Prostatic Neopl...
Prostate Cancer
small urinary c...
45 Years - 80 YearsUniversitaire Ziekenhuizen KU Leuven
Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerNCT01540994
Prostatic Neopl...
radiation thera...
50 Years - 90 YearsSharp HealthCare
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationNCT00126854
Prostatic Neopl...
Magnetic Resona...
18 Years - AHS Cancer Control Alberta
CT/MRI Co-registration Prostate CancerNCT00252460
Prostatic Neopl...
Computed Tomogr...
18 Years - University Health Network, Toronto
Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical ProstatectomyNCT02526589
Prostatic Neopl...
Anastomosis
18 Years - 90 YearsTampere University Hospital
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.NCT01310894
Prostate Cancer
TOOKAD® Soluble
18 Years - Steba Biotech S.A.
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.NCT01310894
Prostate Cancer
TOOKAD® Soluble
18 Years - Steba Biotech S.A.
Exercise for Physical Health in Men With Prostate CancerNCT00660686
Prostatic Neopl...
Osteoporosis
Resistance Exer...
Flexibility Tra...
18 Years - 100 YearsOHSU Knight Cancer Institute
Organoids From Metastases of Prostate CancerNCT03952793
Prostatic Neopl...
extended biopsy
18 Years - Centre Antoine Lacassagne
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessNCT05968144
Prostatic Neopl...
Survivorship
Frailty
Aging
Dietary recomme...
Time-restricted...
55 Years - University of Maryland, Baltimore
Impact of Exercise on Prognostic Biomarkers Related to Prostate CancerNCT03397030
Prostatic Neopl...
Home-Based Exer...
40 Years - The University of Texas Health Science Center at San Antonio
Bone Health Observational StudyNCT00632905
Prostate Cancer
18 Years - CMX Research
Prostate Cancer Genetic Risk Evaluation and Screening StudyNCT05129605
Prostatic Neopl...
Prostate Cancer
BRCA2 Mutation
BRCA1 Mutation
ATM Gene Mutati...
MMR Mutation
Lynch Syndrome
Genetic Predisp...
Prostate cancer...
35 Years - 74 YearsMassachusetts General Hospital
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCNCT05849298
Prostatic Neopl...
AAA617
AAA517
Piflufolastat F...
ARPI
ADT
Best supportive...
18 Years - Novartis
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.NCT03361969
Prostatic Neopl...
Estetrol
Placebo Oral Ta...
18 Years - Pantarhei Oncology B.V.
Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer PatientsNCT01696539
Prostatic Neopl...
Walking Interve...
Standard of Car...
40 Years - 80 YearsÖrebro University, Sweden
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCNCT05849298
Prostatic Neopl...
AAA617
AAA517
Piflufolastat F...
ARPI
ADT
Best supportive...
18 Years - Novartis
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerNCT00001446
Prostatic Neopl...
thalidomide
- National Institutes of Health Clinical Center (CC)
Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical ProstatectomyNCT02526589
Prostatic Neopl...
Anastomosis
18 Years - 90 YearsTampere University Hospital
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold KitNCT03183544
Prostatic Neopl...
Gallium-68 PSMA...
18 Years - 70 YearsCliniques universitaires Saint-Luc- Université Catholique de Louvain
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate CancerNCT03104907
Prostatic Neopl...
Lower Urinary T...
Urological Mani...
Prostatic Disea...
Prostatic Arter...
- Rigshospitalet, Denmark
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.NCT06046131
Prostatic Neopl...
Adenocarcinoma
Neoplasm Recurr...
Neoplasm Metast...
Standard care
18 Years - Centre Hospitalier Universitaire de Pointe-a-Pitre
Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerNCT01540994
Prostatic Neopl...
radiation thera...
50 Years - 90 YearsSharp HealthCare
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized TrialNCT00247312
Prostatic Neopl...
Pd-103
- Schiffler Cancer Center
Open Anterograde Radical Prostatectomy Compared to Open Retrograde TechniqueNCT02687308
Prostatic Cance...
Prostatic Neopl...
1 Retrograde ra...
2 Anterograde r...
40 Years - 80 YearsRio de Janeiro State University
68Ga PSMA in Preprostatectomy PatientsNCT03388346
Prostate Cancer
Prostatic Neopl...
Prostatic Neopl...
Prostatic Neopl...
Ga-68 PSMA-HBED...
18 Years - University of Iowa
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerNCT04225299
Localized Prost...
TOOKAD®
18 Years - Steba Biotech S.A.
Detection Rate of Prostate Cancer in Men Undergoing MRINCT04398173
Prostatic Neopl...
multiparametric...
50 Years - Fondazione del Piemonte per l'Oncologia
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionNCT04266431
Prostatic Neopl...
EMPOWER
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Using WST11 in Patients With Localized Prostate CancerNCT00975429
Prostate Cancer
WST11
WST11
18 Years - Steba Biotech S.A.
A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerNCT00401765
Prostatic Neopl...
CNTO 328
Docetaxel
18 Years - Centocor, Inc.
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical TrialNCT02966535
Prostatic Neopl...
Urinary Bladder...
Adjustment of M...
Adjustment of M...
20 Years - 90 YearsSeoul National University Hospital
Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot StudyNCT02967458
Prostatic Neopl...
Perflutren Lipi...
18 Years - Thomas Jefferson University
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RPNCT05667636
Prostatic Neopl...
salvage SBRT
18 Years - Regina Elena Cancer Institute
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior RadiotherapyNCT03253744
Prostate Cancer
Prostatic Neopl...
18F-DCFPyL
Tumor Irradiati...
Prostate + tumo...
Tumor Irradiati...
18 Years - National Institutes of Health Clinical Center (CC)
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior RadiotherapyNCT03253744
Prostate Cancer
Prostatic Neopl...
18F-DCFPyL
Tumor Irradiati...
Prostate + tumo...
Tumor Irradiati...
18 Years - National Institutes of Health Clinical Center (CC)
MyProstateScore Equivalency With and Without DRENCT05700370
Prostate Cancer
MyProstateScore
45 Years - LynxDx
Preop Conformal Radiotherapy - ProstateNCT00252447
Prostatic Neopl...
Pre-Operative C...
18 Years - University Health Network, Toronto
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold KitNCT03183544
Prostatic Neopl...
Gallium-68 PSMA...
18 Years - 70 YearsCliniques universitaires Saint-Luc- Université Catholique de Louvain
Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With BiopsyNCT03242265
Immunity, Innat...
Prostatic Neopl...
IVDD for NK cel...
18 Years - ATGen Canada Inc
Study of WST11 in Patients With Localized Prostate CancerNCT00707356
Prostate Cancer
WST11
18 Years - Steba Biotech S.A.
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate CarcinomaNCT00001266
Prostatic Neopl...
Suramin
- National Institutes of Health Clinical Center (CC)
SLPI for Prostate CancerNCT04854343
Prostate Cancer
Prostatic Neopl...
Secretory leuko...
Determination o...
Secretory leuko...
18 Years - University of Florence
Exercise for Physical Health in Men With Prostate CancerNCT00660686
Prostatic Neopl...
Osteoporosis
Resistance Exer...
Flexibility Tra...
18 Years - 100 YearsOHSU Knight Cancer Institute
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerNCT01337518
Prostatic Neopl...
EZN-4176
18 Years - Enzon Pharmaceuticals, Inc.
Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR BrachytherapyNCT01936883
Prostate Cancer
HDR
LDR
45 Years - 80 YearsBritish Columbia Cancer Agency
Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer PatientsNCT01696539
Prostatic Neopl...
Walking Interve...
Standard of Car...
40 Years - 80 YearsÖrebro University, Sweden
Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyNCT01316458
Prostatic Neopl...
Genital Neoplas...
Neoplasms, Abdo...
Urogenital Neop...
Genital Disease...
Prostatic Disea...
Antineoplastic ...
Imatinib
STI571 (Glivec®...
18 Years - Novartis
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateNCT01996696
Prostatic Neopl...
Metformin
Placebo
18 Years - AHS Cancer Control Alberta
Urinary and Prostate Microbiotes and Prostate CancerNCT03947515
Prostatic Neopl...
prostate biopsy
Urinary samplin...
Rectal swabbing...
18 Years - Centre Hospitalier Universitaire de Nice
Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate CancerNCT03693703
Prostatic Neopl...
bi-parametric M...
multi-parametri...
18 Years - 75 YearsFondazione del Piemonte per l'Oncologia
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate CancerNCT00769795
Prostate Cancer
IMC-A12
Bicalutamide
Goserelin
18 Years - University of Washington
The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic ProstatectomyNCT05566405
Prostatic Neopl...
General Anaesth...
Combined (Epidu...
Open Retropubic...
- Sismanoglio General Hospital
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate CancerNCT03389451
Prostate Cancer
Prostatic Neopl...
Prostatic Neopl...
Prostatic Cance...
Prostatic Cance...
Ga-68 PSMA-HBED...
18 Years - University of Iowa
Treatment Patterns in Metastatic Prostate CancerNCT02729103
Prostatic Neopl...
Xofigo (Radium ...
45 Years - Bayer
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenNCT01314118
Prostate Cancer
Prostatic Neopl...
abiraterone ace...
18 Years - 99 YearsJanssen Biotech, Inc.
Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic SurgeryNCT02977143
Prostatic Neopl...
Urinary Bladder...
Fluid loading o...
20 Years - Seoul National University Hospital
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate CancerNCT00426777
Prostate Cancer
risedronate
risedronate
Control
18 Years - CMX Research
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsNCT00001444
Breast Cancer
Lymphoma
Neoplasm
Prostatic Neopl...
7-hydroxystauro...
- National Institutes of Health Clinical Center (CC)
Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate CancerNCT01875393
Prostate Cancer
TOOKAD® Soluble
18 Years - Steba Biotech S.A.
68Ga PSMA in Preprostatectomy PatientsNCT03388346
Prostate Cancer
Prostatic Neopl...
Prostatic Neopl...
Prostatic Neopl...
Ga-68 PSMA-HBED...
18 Years - University of Iowa
Organoids From Metastases of Prostate CancerNCT03952793
Prostatic Neopl...
extended biopsy
18 Years - Centre Antoine Lacassagne
SLPI for Prostate CancerNCT04854343
Prostate Cancer
Prostatic Neopl...
Secretory leuko...
Determination o...
Secretory leuko...
18 Years - University of Florence
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsNCT00666926
Head and Neck N...
Prostatic Neopl...
Pancreatic Neop...
PF00562271
PF00562271
PF00562271
PF00562271
18 Years - Verastem, Inc.
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionNCT06292897
Prostate Cancer
Prostate Adenoc...
Prostate Neopla...
Prostatic Neopl...
Obesity
observational s...
18 Years - Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionNCT06292897
Prostate Cancer
Prostate Adenoc...
Prostate Neopla...
Prostatic Neopl...
Obesity
observational s...
18 Years - Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsNCT03935282
Breast Neoplasm
Prostatic Neopl...
Colorectal Neop...
Endometrial Neo...
Hodgkin Disease
Non Hodgkin Lym...
AH-HA Tool in t...
18 Years - Wake Forest University Health Sciences
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RPNCT05667636
Prostatic Neopl...
salvage SBRT
18 Years - Regina Elena Cancer Institute
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate CancerNCT00769795
Prostate Cancer
IMC-A12
Bicalutamide
Goserelin
18 Years - University of Washington
Study Using WST11 in Patients With Localized Prostate CancerNCT00975429
Prostate Cancer
WST11
WST11
18 Years - Steba Biotech S.A.
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate CancerNCT04484701
Prostatic Neopl...
Prostatic Cance...
68Ga-PSMA-11
19 Years - 99 YearsBritish Columbia Cancer Agency
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerNCT00001446
Prostatic Neopl...
thalidomide
- National Institutes of Health Clinical Center (CC)
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized TrialNCT00243646
Prostate Cancer
External beam r...
Lupron
Casodex
- Schiffler Cancer Center
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerNCT01431391
Prostatic Neopl...
Prostate Cancer
Prostatic Adeno...
sipuleucel-T
leuprolide acet...
18 Years - Dendreon
Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)NCT04332744
Metastatic Pros...
Enzalutamide
Talazoparib
18 Years - MedSIR
Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyNCT01316458
Prostatic Neopl...
Genital Neoplas...
Neoplasms, Abdo...
Urogenital Neop...
Genital Disease...
Prostatic Disea...
Antineoplastic ...
Imatinib
STI571 (Glivec®...
18 Years - Novartis
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessNCT05968144
Prostatic Neopl...
Survivorship
Frailty
Aging
Dietary recomme...
Time-restricted...
55 Years - University of Maryland, Baltimore
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: